Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Therapies02:49

Cancer Therapies

7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer.

Nature reviews. Clinical oncology·2026
Same author

plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer.

Cancer research communications·2026
Same author

How Much Is Enough? Ultra-Low Doses of Immunotherapy to Improve Access and Affordability.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer. Reply.

The New England journal of medicine·2025
Same author

Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survival.

Cancer·2025

相关实验视频

Updated: May 12, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K

针对可切除肺癌的免疫疗法

Colum Dennehy1, Michael R Conroy1, Patrick M Forde1

  • 1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Cancer
|May 7, 2025
PubMed
概括

新辅助和外科期间的免疫疗法对早期肺癌有望,改善存活率并减少复发. 选择患者和管理副作用的挑战仍然是研究的关键领域.

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学

背景情况:

  • 肺癌是全球领先的健康问题.
  • 免疫检查点封锁是高级和早期切除肺癌的标准治疗方法.

研究的目的:

  • 审查肺癌中新辅助和外科期免疫治疗的现状和未来方向.
  • 分析临床试验结果,安全概况以及对复发和生存的影响.

主要方法:

  • 对可切除肺癌的新辅助和术后免疫疗法进行临床试验和现有文献的综述.
  • 分析疗效,安全性,患者选择,治疗计划和手术影响.

主要成果:

  • 新辅助和术后免疫疗法显示出早期疗效,并影响可切除肺癌的疾病复发和存活率.
  • 关键的挑战包括优化患者选择,治疗时间,管理与免疫相关的不良事件和外科考虑.

结论:

  • 免疫疗法为手术切除的肺癌提供了一个有前途的治疗策略.
  • 需要进一步的研究来克服挑战,并建立最佳的新辅助和周围手术免疫治疗方案.
关键词:
一个辅助的辅助者.免疫检查点是一个检查点.免疫疗法 免疫疗法局部化的局部化的局部化肺癌是一种肺癌.这是一种新辅助剂.非小细胞肺癌 (NSCLC) 是一种非小细胞肺癌.在外科手术期间的外科手术.可切除的可切除物手术 手术 手术 手术 手术 手术 手术

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

16.6K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

502

相关实验视频

Last Updated: May 12, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

16.6K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

502